![Glycosaminoglycans / Oral and maxillofacial surgery / Oral surgery / Restylane / Hyaluronan / Lip enhancement / Adverse event / Food and Drug Administration / Medical device / Medicine / Clinical research / Pharmaceutical industry Glycosaminoglycans / Oral and maxillofacial surgery / Oral surgery / Restylane / Hyaluronan / Lip enhancement / Adverse event / Food and Drug Administration / Medical device / Medicine / Clinical research / Pharmaceutical industry](https://www.pdfsearch.io/img/9276a991d0555bb1291662210b442350.jpg)
| Open Document File Size: 208,12 KBShare Result on Facebook
City Study / Protocol / Scottsdale / / Company Medicis Aesthetics Inc. / Applicant/Manufacturer Information Medicis Aesthetics Inc. / Executive Summary Medicis Aesthetics Inc. / / Currency pence / / Event FDA Phase / / IndustryTerm manufacturing information / / MedicalTreatment Restylane / Plastic and Reconstructive Surgery / / Organization FDA / Division of Surgical / Orthopedic / and Restorative Devices / Food and Drug Administration / Center for Devices and Radiological Health / / Position General / Treating Investigator / Blinded Evaluator / Executive / / Product P040024 / MA-1300-15 / / ProvinceOrState Arizona / / PublishedMedium the FDA review / / Technology research protocols / /
SocialTag |